NPI registry status
Active
2026 NPPES data Gynecologic Oncology Physician NPI 1013172022 D.O.
Verify on CMS → Kristopher Lybarger, D.O.
Gynecologic Oncology Physician in Kansas City, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,407 in Gynecologic Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
437
Medicare Part D claims · 129 beneficiaries · Gynecologic Oncology Physician avg: 198
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$187.5K
203 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Kristopher Lybarger, D.O. filed 437 Medicare Part D claims in 2024 as a Gynecologic Oncology Physician in Kansas City, Missouri, prescribing 95% generic.
- 437
- Part D claims, 2024
- 95%
- generic prescribing
- $187.5K
- industry payments (Sunshine Act)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Kristopher Lybarger, D.O.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1013172022), first enumerated 07/20/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 437 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$187.5K in reported industry payments (203 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1013172022 · Gynecologic Oncology Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1013172022
- ENUM-MID 2008
- TAX-NARROW 1,407
- RX-LIGHT 437
- BOOK-THIN 40 in Missouri
- PHOTO-ENUM Kristen Bunch, DO · 2008
Kristopher Lybarger, D.O.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
437 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Kristopher Lybarger, D.O. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kristopher Lybarger, D.O.?
Quality data not reportedPrimary specialty
Gynecologic Oncology Physician
Medicare Part D claims
437 121% vs specialty avg
Specialty distribution in Missouri
How Gynecologic Oncology Physician compares to other specialties among Missouri providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Gynecologic Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1013172022 |
|---|---|
| Specialty | Gynecologic Oncology Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 07/20/2008 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Kristopher Lybarger, D.O.. Source: openpaymentsdata.cms.gov.
Total received
$187.5K
Largest payer
Davol Inc.
Most common payment type
Travel and Lodging
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Kristopher Lybarger, D.O. - brand share 5.0%
Gynecologic Oncology Physician average
5% brand-name claims vs 95% generic, on 437 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
437
Total Claims
$236K
Total Drug Cost
129
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 502.533
- Total Day Supply
- 9,732
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $230K
- Generic Drug Cost
- $6K
- Opioid Claims
- 131 (30.0% rate)
Patient Demographics
- Average Patient Age
- 68.9 years
- Avg HCC Risk Score
- 1.77
- Age Distribution
- <65: 26, 65-74: 61, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Kristopher Lybarger, D.O. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tramadol Hcl
Tramadol Hcl
84 claims
- Gabapentin
Gabapentin
83 claims
- Ibuprofen
Ibuprofen
55 claims
- Letrozole
Letrozole
41 claims
- Megestrol Acetate 21
Megestrol Acetate
21 claims
- Lorazepam 19
Lorazepam
19 claims
- Oxycodone-Acetamin… 18
Oxycodone-Acetaminophen
18 claims
- Hydrocodone-Acetam… 15
Hydrocodone-Acetaminophen
15 claims
| Drug | Claims |
|---|---|
| Tramadol Hcl | 84 |
| Gabapentin | 83 |
| Ibuprofen | 55 |
| Letrozole | 41 |
| Megestrol Acetate | 21 |
| Lorazepam | 19 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 18 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 15 |
| Methylprednisolone | 14 |
| Lynparza Olaparib | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Gynecologic Oncology Physician Overview
How Kristopher Lybarger, D.O. fits within the Gynecologic Oncology Physician landscape nationally.
1,407
Gynecologic Oncology Physician Providers in US
49
States with Gynecologic Oncology Physician
198
Avg Claims per Provider
Kristopher Lybarger, D.O.'s 437 claims are above the specialty average of 198.
Nationwide Gynecologic Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Lybarger, both outside Missouri so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Gynecologic Oncology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Lybarger.
One of 40 Gynecologic Oncology Physician providers enrolled in Missouri, 5 are shown here.
Dr. Nora Badiner
MD
Kansas City, MO
Dr. Albert Bonebrake
MD
Springfield, MO
Dr. Jay Carlson
D.O.
Springfield, MO
Dr. Nishan Chobanian
MD
Saint Louis, MO
Dr. Sara Crowder
MD
Columbia, MO
Compare Gynecologic Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Kristopher Lybarger, D.O.'s specialty? ▼
Kristopher Lybarger, D.O. specializes in Gynecologic Oncology Physician and practices in Kansas City, Missouri. Credentials: D.O..
How much does Kristopher Lybarger, D.O. prescribe under Medicare Part D? ▼
In 2024, Kristopher Lybarger, D.O. wrote 437 Medicare Part D claims totaling $236K in drug costs for 129 beneficiaries.
Where is Kristopher Lybarger, D.O. located? ▼
Kristopher Lybarger, D.O. is located at 2340 E MEYER BLVD BLDG 2, Kansas City, MO, 64132. Phone: (816) 926-0777.
What is Kristopher Lybarger, D.O.'s NPI number? ▼
Kristopher Lybarger, D.O.'s National Provider Identifier (NPI) is 1013172022, issued on 07/20/2008.
Does Kristopher Lybarger, D.O. prescribe more brand-name or generic drugs? ▼
Kristopher Lybarger, D.O.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $230K in brand drug costs.
Does Kristopher Lybarger, D.O. prescribe opioids? ▼
Yes, Kristopher Lybarger, D.O. had 131 opioid claims in 2024 with an opioid prescribing rate of 30.0%.
How many Gynecologic Oncology Physician providers are there in the US? ▼
There are 1,407 Gynecologic Oncology Physician providers across 49 states in the US. The average Gynecologic Oncology Physician provider writes 198 Medicare Part D claims per year.
What drugs does Kristopher Lybarger, D.O. prescribe most often? ▼
Based on 2024 Medicare Part D data, Kristopher Lybarger, D.O.'s most frequently prescribed drugs include Tramadol Hcl, Gabapentin, Ibuprofen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kristopher Lybarger, D.O. accept Medicare? ▼
Kristopher Lybarger, D.O. appears in CMS Medicare data with 437 Part D claims and 129 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kristopher Lybarger, D.O.'s credentials? ▼
Kristopher Lybarger, D.O.'s NPI is 1013172022 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.